Clinical Trial Update: Quetiapine in the Treatment of Psychotic Depression - a Pilot Study [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 pilot trial evaluating quetiapine for psychotic depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder with Psychotic Features

Drugs mentioned

• Quetiapine (quetiapine)

Snippet

Sponsor: Ruhr University of Bochum | Conditions: Psychotic Depression | Phase 3 | Status: COMPLETED